Replies to post #18199 on GTC Biotherapeutics (fka GTCB)

[croumagnon]

"It’s hard to see how a such a multi-legged parlay that produces an outcome of 0.70 (in your opinion) makes GTC a good buy at 0.45-0.50."

First, buying at $0.45 and selling next summer at $0.7 means over 50% return on investment, which in this market is a great achievement! However, the point of my post was to look at the worse case scenario currently, which is a takeover by LFB, and claim that even in that case GTCB is a good investment currently. Perhaps it is wishful thinking on my part but I have to believe that FDA approval, and its implied validation of the technology, has moved the takeover bar for GTCB from the previously anticipated $0.31 per share to at least double that...